AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Scancell Holdings plc
Video analysis: SCNLF
All videosNo video analysis for this stock yet. Request one from our team.
News: SCNLF
Cancer vaccine breakthrough at Moderna raises hopes for Scancell's melanoma programme
A landmark trial success for Moderna and Merck's cancer vaccine has strengthened the case for Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the immuno-oncology company developing a rival melanoma treatment, according to one broker covering the sector's innovative small-caps. Merck and Moderna said on Wednesday that their phase III INTerpath-001 trial of intismeran autogene, an mRNA-based cancer vaccine, met its endpoints in patients with completely resected stage IIB-IV melanoma.
Marvell shares jump as Google warrant deepens AI chip partnership
Marvell Technology Inc (NASDAQ:MRVL) issued Alphabet's Google a warrant to buy up to 58.97 million shares at $206.58 apiece, expanding a custom chip...
Scancell secures UK clearance for late-stage melanoma trial
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the cancer immunotherapy developer, has won UK regulatory approval to run a late-stage trial of its lead drug in advanced melanoma. The Medicines and Healthcare products Regulatory Agency (MHRA) has granted a clinical trial authorisation for the phase III registrational study of iSCIB1+.
Ford and GM upgraded by Jefferies on improving outlooks, stronger cash generation
Ford Motor Company (NYSE:F) and General Motors Company (NYSE:GM) have both been upgraded to ‘Buy’ by Jefferies analysts, who pointed to improving earnings...
Chip stocks slide as China advances domestic lithography, memory production
Shares of major chipmakers fell sharply on Monday after reports that a state-backed Chinese firm has begun mass-producing domestic deep ultraviolet (DUV)...
Scancell sees high demand in retail share offer, seals £15.7m from UK investors
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) confirmed the UK leg of its equity funding has raised gross proceeds of £15.7 million after strong retail demand prompted the cancer immunotherapy developer to increase the size of its retail offer. The retail offer raised £2.7 million, above the original £2.3 million target.
SMALL-CAP MOVERS: Nasdaq-bound Scancell catches the eye as AIM's headcount falls to 612
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP) saw its shares drop 27% this week, but the movement obscures the real story, which is a largely...
American Airlines shares fall as fuel costs weigh on third-quarter outlook despite earnings beat
American Airlines Group Inc (NASDAQ:AAL, XETRA:A1G) shares fell about 8% Thursday after the carrier reported better-than-expected second quarter results but...
